Increased chronic exposure to airborne particulate matter with aerodynamic diameter smaller than 2.5 μm (PM 2.5 ) increases risk for coronary heart disease (CHD). 1 Many studies using a variety of epidemiologic designs have replicated this finding. Hypothesized mechanisms for the effect of chronic exposure to ambient air pollution on cardiovascular health include systemic inflammation, oxidative stress, and other proatherosclerotic mechanisms. 1 Despite this large number of studies, most of the evidence for the relationship between fine particulate matter and incident CHD is based upon cohort studies in whites, 2, 3 comprised of either only males 4 or only females 5, 6 who live in urban areas. [7] [8] [9] [10] Restriction of study samples to these populations has often been a function of the large cohort data that were available at the time the study was conducted, or the need to sample participants near air quality monitoring stations operated by the Environmental Protection Agency (EPA) to obtain robust exposure assessments. The effects of PM 2.5 on CHD may not generalize to populations who were not represented in these study samples. Therefore, we assessed the association between chronic PM 2.5 exposure and incident CHD in a national cohort of white and black participants of both genders living in both urban and rural areas across the continental United States.
Methods

Study population
We used a subsample of the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort who were free of CHD at baseline. REGARDS is a nationwide study of 30,239 black and white participants age 45 years and older of both genders recruited between 2003 and 2007, designed to investigate the causes for increased stroke mortality in 8 southeastern states (ie, the "Stroke Belt"), as well as for the increased stroke mortality in blacks compared with whites. Participants were recruited by mail and phone, with oversampling of participants from the Stroke Belt and Stroke Buckle (coastal plains of North Carolina, South Carolina, and Georgia), as well as oversampling of blacks. A baseline computer-assisted telephone interview (CATI) was conducted to collect demographic and health-related variables. After the baseline CATI, an in-home visit was performed by a trained health professional who collected anthropometric measurements such as height, weight, and blood pressure, as well as collected blood and urine samples and an electrocardiogram.
Outcomes
Potential CHD events were detected during a follow-up CATI conducted every 6 months. A report of a hospitalization or emergency department visit for any reason related to the heart triggered medical record retrieval. If proxies reported that the participant was deceased or if national database searches revealed that the participant was deceased, medical records, autopsy reports, and death certificates were retrieved, and the proxy was interviewed about the circumstances immediately contiguous with the demise. Cases were then adjudicated by experts using all available materials following national consensus guidelines. 11, 12 A definite or probable myocardial infarction (MI) was present based on the presence of ischemic signs and symptoms; a rising and falling pattern of cardiac biomarkers, most often troponin, to a peak of at least twice the upper limit of normal over at least 6 hours; and electrocardiogram or other imaging evidence consistent with ischemia, following the Minnesota code. Independent adjudication had a κ statistic for agreement N0.80. CHD death was present if a person died within 28 days of a definite or probable MI, or evidence was incomplete to adjudicate an MI but the circumstances were highly suggestive of CHD as the underlying cause of death.
We investigated the impact of PM 2.5 on 3 outcomes: incident total CHD, incident CHD death, and incident nonfatal MI. Incident total CHD was defined as definite or probable MI or acute CHD death, whichever occurred first. Incident CHD death was defined as a CHD death without an antecedent nonfatal MI. Incident nonfatal MIs were definite or probable MIs that did not result in death within 28 days. Events through December 31, 2012, were available for this analysis.
Exposure assessment
One-year mean PM 2.5 concentrations were estimated for each participant at baseline. Geocoding was performed using SAS (Cary, NC) and the participant's street address, and we assumed that participants resided at their baseline address throughout follow-up. Approximately 20% of the REGARDS participants did not live in urban areas, so traditional methods of spatially smoothing only ground-level monitoring stations could have resulted in biased exposure assessments. Therefore, the estimates of chronic exposure were created using daily PM 2.5 exposures for each participant that were estimated using a combination of EPA Air Quality System (AQS) groundlevel measurements of PM 2.5 concentration and satellite measurements of aerosol optical depth (AOD) from the MODerate resolution Imaging Spectroradiometer (MODIS) instrument on the National Aeronautics and Space Administration (NASA) Aqua satellite, which estimates the amount of particulate matter in the air column. 13, 14 The AOD and AQS measurements were combined by using previously published regression models for each US EPA region and season to predict ground-level PM 2.5 concentrations from MODIS satellite AOD measurements. 15 Then, the national data set of AQS measurements was combined with the predicted PM 2.5 concentrations from the regression models. Finally, a b-spline smoothing algorithm was used to spatially smooth the ground-level PM 2.5 estimates, with greater weight given to the AQS measurements. 13, 14 The final spatial resolution of the estimated surface was 10 km × 10 km and covered the continental United States. This combination of ground-level and satellite data helped to overcome the limited spatial coverage of AQS monitoring stations, particularly for rural participants in REGARDS, as well as the indirect nature of MODIS-derived measurements.
Measurement of covariates
Framingham Risk Score. Using the self-reported variables and laboratory values from blood samples collected during the baseline CATI and in-home visit, respectively, the Framingham Risk Score (FRS) for CHD was calculated for each participant. 16 The FRS consists of the following risk factors: age, high-density lipoprotein cholesterol, total cholesterol, systolic blood pressure, diastolic blood pressure, diabetes status, and smoking status. High-density lipoprotein cholesterol and total cholesterol were measured from the blood samples taken at the baseline in-home visit. Blood pressure values were an average of 2 measurements taken after the participant had been seated for 5 minutes. Participants were considered to have diabetes if their nonfasting glucose was ≥200 mg/dL, if their fasting glucose was ≥126 mg/dL, or if the participant self-reported use of insulin or medication to treat diabetes. Participants were classified as smokers if they reported current smoking. After calculating the FRS for each individual, participants were classified as "low risk factor burden" if their FRS was b10% and as "high risk factor burden" if their FRS was ≥10%. We used this classification, as opposed to other more common classifications with more categories, because of the limited number of events in each combination of risk category.
Other covariates. The following variables were included as potential confounders of the relationship between PM 2.5 and risk for CHD: 1-year mean baseline temperature (degrees Celsius), season at baseline, urbanicity (rural, mixed, or urban), and calendar year of the baseline visit. Temperature was assessed using the North American Land Data Assimilation System, which provides daily estimates of several meteorological variables on an approximately 12-km by 12-km grid across the continental United States. 14, 17 Urbanicity was defined based on census data, describing the percentage of the participant's census tract that was classified as urban area: no more than 25% urban area was rural, 25%-75% was mixed, and at least 75% urban area was urban.
Other variables were included as potential confounders of the relationship between FRS and risk for CHD: age (years), race (black or white), region of residence (Stroke Buckle [coastal plains of North Carolina, South Carolina, and Georgia], Stroke Belt [North Carolina, South Carolina, Georgia, Tennessee, Alabama, Mississippi, Arkansas, and Louisiana], or rest of the United States), income (b$20,000, $20,000-$34,000, $35,000-$74,000, at least $75,000, and declined to report), education (less than high school, high school graduate, some college, and college graduate and above), diabetes (as defined above), current use of antihypertensive medications, current use of statins, body mass index (BMI; kg/m 2 ), pack-years of cigarette smoking, alcohol use (none, moderate [≤14 drinks/wk for men and ≤7 drinks/wk for women], and heavy [N14 drinks/wk for men and N7 drinks/wk for women]), and physical activity (none, 1-3 times per week, and 4 or more times per week). Another reason for including age, gender, pack-years of smoking, and diabetes was to account for possible residual confounding even though they are included in the FRS. Race, age, gender, income, education, pack-years of smoking, alcohol use, physical activity, and current use of antihypertensive medications were self-reported during the CATI at baseline; region of residence was assigned based upon the participant's geocoded street address; and current statin use was assessed using pill bottle review during the in-home visit. BMI and diabetes classification were determined using measurements and blood samples collected during the in-home visit.
Statistical methods
We first summarized the risk factor burden, potential confounders, and outcomes of the cohort by quartile of baseline 1-year mean PM 2.5 exposure. We then calculated event rates and 95% CIs for total CHD for each combination of baseline risk factor burden (low or high) and quartile of baseline 1-year mean PM 2.5 exposure.
We used Cox proportional hazards models to estimate the relationship between PM 2.5 exposure and incident CHD, first without an interaction between PM 2.5 exposure and risk factor burden summarized by the FRS and then including an interaction between PM 2.5 exposure and risk factor burden. This analysis was prespecified, given the recent work focusing on identifying subpopulations that might have differential risk for CHD due to PM 2.5 exposure. 18 We fit models for 3 separate outcomes: (1) total CHD (combined CHD death and nonfatal MI); (2) CHD death, with nonfatal MIs censored; and (3) nonfatal MI, with CHD death censored. Model 1 for each outcome included 1-year mean temperature, season, race, region, urbanicity, income, education, age, gender, pack-years, BMI, alcohol use, physical activity, and calendar year, whereas model 2 added terms for statin use, antihypertensive medication use, and diabetes. The 3 additional covariates in model 2 were left out of model 1 because they could potentially be a part of the causal pathway between PM 2.5 and risk for CHD. We investigated modeling PM 2.5 and temperature using restricted cubic splines but found that linear modeling was sufficient (data not shown).
We also conducted sensitivity analyses to test for interactions between PM 2.5 and gender, PM 2.5 and race, and PM 2.5 and urbanicity each with the same covariates as in model 2. These post hoc sensitivity analyses were conducted to pursue possible discrepancies between our results and results from previous studies.
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Results
The present study excluded those with anomalous data (n = 56), were missing the date of their in-home visit (n = 14), were missing location data (n = 11), were missing baseline CHD variable (n = 567), had baseline CHD (n = 5,310), had no follow-up data in REGARDS (n = 395), were missing their pill bottle review data (n = 63), had low certainty in their geocoded location of residence (n = 3,671), were missing education status (n = 14), were missing their FRS (n = 1,127), were missing self-reported use of antihypertensive medications (n = 749), were missing alcohol use (n = 322), were missing physical activity (n = 257), were missing BMI (n = 78), or were missing pack-years (n = 479), leaving a final analytic sample size of 17,126.
Of the 17,126 participants included in this study, 43% were black and 58% were female. The median (25th-75th percentile) age at baseline was 63 (57-71) years, and the median follow-up time was 6 years. Ten percent of the participants lived in rural areas, 10% lived in mixed areas, and 80% lived in urban areas. Thirty-four percent of the cohort had a high baseline risk factor burden. There were 628 total CHD events (215 CHD deaths and 413 nonfatal MIs). The median (25th-75th percentile) 1-year mean PM 2.5 concentration was 13.6 μg/m 3 (12.1-14.8). Descriptive statistics by quartile of PM 2.5 baseline concentration are presented in Table I . Figure 1 and Supplemental Table I present crude total CHD event rates per 1,000 person-years for each combination of baseline risk factor burden and quartile of baseline PM 2.5 exposure. The highest event rate was 12.9 CHD events per 1,000 person-years, among participants with high risk factor burden in the second quartile of baseline exposure to PM 2.5 , whereas the lowest event rate was 3.2 CHD events per 1,000 person-years, among participants with low risk factor burden in the highest quartile of PM 2.5 exposure. The Cox proportional hazards models were fit and proportional hazards were assessed using Schoenfeld residuals. 19 The proportional hazards assumption was deemed satisfied through visual inspection of scatterplots of residuals of each variable versus log time. Estimated hazard ratios (HRs) for all model terms for total CHD are presented in Table II, for CHD death in Supplemental  Table II , and for nonfatal MI in Supplemental Table III . In fully adjusted models for total CHD (model 2), the HR for a 2.7-μg/m 3 increase (interquartile range) PM 2.5 exposure modeled linearly was 0.94 (95% CI 0.83-1.06), indicating no statistically significant evidence of a relationship between total CHD and chronic exposure to PM 2.5 . The HR for the same increase in PM 2.5 Figure 2 shows the predicted log hazard for each value of PM 2.5 for each outcome.
In models that included an interaction between PM 2.5 and risk factor burden, the interaction was not statistically significant for total CHD (P = .44), for CHD death (P = .47), or for nonfatal MI (P = .09). In models for total CHD, sensitivity analyses did not identify statistically significant interactions between PM 2.5 exposure and gender (P = .998), race (P = .85), or urbanicity (P = .40). None of these interactions were significant for either CHD death or nonfatal MI (data not shown).
Discussion
Previous studies of the relationship between chronic exposure to ambient fine particulate matter and CHD have usually been restricted to one gender, whites, and/ or participants living in urban areas. These restrictions could indicate that many estimates of the relationship between chronic exposure to fine particulate matter and CHD risk are not generalizable. In a cohort of whites and blacks of both genders living in both rural and urban areas across the United States, we were not able to identify statistically significant associations between 1-year mean concentrations of PM 2.5 and total CHD or CHD death. We did identify a slightly statistically significant inverse relationship between PM 2.5 exposure and nonfatal MI. We were not able to identify statistically significant effect modification of these relationships by baseline risk factor Event rates and 95% CIs of incident CHD by baseline 1-year mean PM 2.5 concentration and baseline risk factor burden for CHD in REGARDS sample.
burden, gender, race, or urbanicity. In summary, we were not able to identify any definitive evidence for a relationship between 1-year mean concentration of fine particulate matter and incident CHD in a geographically and demographically heterogeneous national cohort.
Previous studies have found associations between increased chronic PM 2.5 exposure and increased risk for CHD, and the cardiovascular disease epidemiology community currently accepts that chronic exposure to high concentrations of PM 2.5 has a causal effect on CVD outcomes. 1 The association with CHD has tended to be found in women 2, 6 and not men, 2, 4 with the estimated HRs varying from 0.90 to 2.02 for CHD death for a 10-μg/m 3 increase in chronic PM 2.5 exposure (Supplemental Table IV ). Although we reported HRs for a 2.7-μg/m 3 increase in PM 2.5 concentration given the limited variability in our data, a 10-μg/m 3 increase in our study would have had an associated HR of approximately 1.6. Thus, our estimated association for CHD death falls within a reasonable range, given prior studies' results. The inverse association we detected between PM 2.5 exposure and nonfatal MI was also seen in the Nurses' Health Study, although it was not statistically significant in that sample. 6 We conclude that the results from our study fall into the highly variable range of estimated associations between chronic exposure to fine particulate matter and incident CHD. Although we hypothesized that the limited heterogeneity of previous studies in terms of race, gender, and urban residence might affect generalizability, we found no evidence that our results depended upon race, gender, or type of residence (rural, mixed, or urban).
There were some important differences between our study and previous studies that require mention, most notably the method of estimating PM 2.5 . We integrated both ground-level measurements of PM 2.5 and satellite measurements of AOD to predict ambient PM 2.5 over a large spatial area (continental United States). Al-Hamdan et al (2009) showed that merging these remotely sensed data with surface observations of PM 2.5 not only provided a more complete daily representation of PM 2.5 than either data set alone would allow, but it also resulted in an average of 16% reduction in the root mean squared difference between the predicted/smoothed and observed PM 2.5 concentrations compared with predicted PM 2.5 surfaces that used only observed values from AQS monitoring stations. 13 We have used this same method for estimating PM 2.5 exposure in studies of incident cognitive impairment 20 and stroke, 21 for which we also did not identify associations with PM 2.5 concentration. Additionally, given the large area over which spatial prediction was performed (ie, the continental United States), we could justify prediction at 10-km by 10-km grid blocks only, meaning that participants in the same city had a high probability of having identical PM 2.5 values for each day they were in the study. Previous studies in smaller urban areas could justify prediction at much higher spatial resolutions, which resulted in more variability in predicted PM 2.5 concentrations. However, a recent study in Canada using the same spatial resolution as our study found associations with chronic PM 2.5 exposure and incident fatal CHD, indicating that the larger spatial scale we used did not preclude the identification of statistically significant associations per se. 3 Another potential cause of our slightly different inference compared with previous studies is the secular decrease in the mean and variance of PM 2.5 concentration levels in the United States. Finally, PM 2.5 is a heterogeneous mixture, and the mixture could vary between rural and urban areas, leading to associations that depend on location, as have been seen for PM 2.5 and term low birth weight. 22 Our study had a few limitations worth noting. We used an estimated value for PM 2.5 concentration, with the assumption that participants did not relocate from their baseline address, creating uncertainty in the estimations of exposure for a given participant. These estimates included information from ground-level measurements from AQS stations potentially far away from a participant, leading to the possible induction of a Berkson error, which can bias estimates of association between an exposure and an outcome. 23 However, the inclusion of estimated PM 2.5 values from AOD measurements much nearer to the participant's residence likely reduced the effect of this exposure-outcome spatial misalignment, but we concede that exposure misclassification could still be present, particularly because we could not compare these predicted PM 2.5 values with observed values from AQS stations given the lack of coverage of these stations in rural areas. MODIS measurements are also subject to limited spatial coverage depending upon the season, land surface terrain, and cloud cover. Estimates of ambient PM 2.5 exposure are only a proxy for an individual's actual daily exposure, which depends on his or her amount of outdoor physical activity or occupational exposure. We excluded participants who did not have sufficiently high certainty in the participant's geocoded location, which preferentially excluded rural participants and might limit the generalizability of our results.
Despite the limitations, there are also several strengths to our study. As opposed to previous studies, we were able to expand our participant population outside metropolitan areas, as well as expand the population to cover the entire continental United States. This larger population and more geographically diverse sample allowed us to achieve greater generalizability than previous studies and also allowed us to control for confounding by urbanicity of residence (rural, mixed, or urban). We also had a large cohort of black and white participants of both genders, whereas some previous studies had only one gender and/or race. The in-home visit in the REGARDS study provided measured variables for all participants, such as blood pressure, which reduced the potential for misclassification of risk factor burden due to geographic variation in self-report bias, which has been documented for self-reported BMI. 24 Finally, because blood samples were obtained from all participants, we were able to calculate the FRS, a summary of risk factor burden for CHD.
In conclusion, we did not find evidence that chronic PM 2.5 exposure was associated with incident CHD, except for a possible inverse association with nonfatal MI. We cannot conclude from our study that there is no relationship between PM 2.5 exposure and incident CHD among REGARDS participants, but we do hypothesize that the generalizability of estimates of the effects of chronic exposure to ambient fine particulate matter and CHD requires further study, particularly among populations consisting of multiple races and persons living in nonurban areas. A lack of generalizability could lead to policies on air pollution that are not optimal for all persons. Predicted log hazard for incident total CHD, CHD death, and nonfatal MI versus previous 1-year mean ambient PM 2.5 concentration. Gray bands are 95% prediction intervals.
